• Transplantation

  The Future Of Lung Transplantation

  Posted by Colleen on July 16, 2019 at 8:00 am

  

  Martine Rothblatt is the founder of United Therapeutics and her team developed the pulmonary hypertension medication, Remodulin. Now her ambition is to tackle the organ shortage in America with technology and genetic engineering. Here is an article about how she is putting her goal into action and what it could mean for the future of transplantation.

  What are your thoughts about what she is trying to accomplish?

  https://www.cnbc.com/2019/06/26/a-ceo-who-wants-to-genetically-modify-pig-organs-for-human-transplant.html

  replied 6 years, 8 months ago 1 Member · 0 Replies

  • Future of Lung Transplant
  • Genetic Engineering
  • Organ Shortage
  • remodulin
• 0 Replies

Log In to Reply